NASDAQ : SNDX
Syndax Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 14.15 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.26B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Syndax Pharmaceuticals, Inc. (SNDX) reported revenue of 289.68M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 289.68M | 172.35M | 23.68M | 139.71M | ||
| Cost of Revenue | 281.33M | 265.75M | 242.47M | 163.03M | 118.50M | |
| Gross Profit | 8.35M | -93.40M | -218.79M | -163.03M | -118.50M | 139.71M |
| Selling, General & Admin | 172.77M | 179.68M | 120.88M | 66.92M | 33.26M | 25.24M |
| Research & Development | 14.22M | 88.25M | ||||
| Operating Expenses | 186.99M | 179.68M | 120.88M | 66.92M | 33.26M | 113.49M |
| Operating Income | -178.64M | -273.08M | -339.67M | -229.95M | -151.76M | 26.22M |
| Interest Expense | -47.09M | -33.78M | -4.93M | -208.00K | -3.14M | -1.90M |
| Interest & Investment Income | 17.23M | 22.73M | 26.09M | 21.16M | 5.87M | 403.00K |
| Other Non Operating Income (Expenses) | -978.00K | -1.28M | -247.00K | -361.00K | -316.00K | 202.00K |
| Pretax Income | -209.48M | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| Net Income | -209.48M | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| Net Income to Common | -209.48M | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| Shares Outstanding (Basic) | 88.49M | 86.63M | 85.62M | 70.37M | 60.76M | 52.06M |
| Shares Outstanding (Diluted) | 88.49M | 86.63M | 85.62M | 70.37M | 60.76M | 53.62M |
| EPS (Basic) | -2.37 | -3.29 | -3.72 | -2.98 | -2.46 | 0.48 |
| EPS (Diluted) | -2.37 | -3.29 | -3.72 | -2.98 | -2.46 | 0.46 |
| Free Cash Flow | -177.46M | -323.17M | -274.90M | -160.60M | -133.68M | 29.00M |
| Free Cash Flow Per Share | -2.00 | -3.73 | -3.21 | -2.28 | -2.20 | 0.54 |
| Gross Margin | 2.88% | -54.19% | 100.00% | |||
| Operating Margin | -61.67% | -158.45% | -1,434.43% | 18.77% | ||
| Profit Margin | -72.32% | -165.60% | -1,346.11% | 17.84% | ||
| Free Cash Flow Margin | -61.26% | -187.50% | -1,160.91% | 20.76% | ||
| EBITDA | -178.62M | -273.08M | -339.66M | -229.94M | -151.72M | 26.26M |
| EBITDA Margin | -61.66% | -158.44% | 18.80% | |||
| D&A For EBITDA | 18.00K | 6.00K | 8.00K | 12.00K | 33.00K | 43.00K |
| EBIT | -178.64M | -273.08M | -339.67M | -229.95M | -151.76M | 26.22M |
| EBIT Margin | -61.67% | -158.45% | 18.77% | |||
| Revenue as Reported | 289.68M | 172.35M | 23.68M | 139.71M | ||
| Advertising Expenses | 14.40M | 7.30M | 6.10M | 1.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 135.94M | 134.93M | 154.08M | 295.39M | 74.36M | 221.97M |
| Short-Term Investments | 301.32M | 278.76M | 428.83M | 282.19M | 410.04M | 224.87M |
| Cash & Short-Term Investments | 437.26M | 413.69M | 582.91M | 577.58M | 484.40M | 446.83M |
| Accounts Receivable | 46.87M | 38.00M | 7.60M | |||
| Other Receivables | 29.85M | 32.30M | 6.27M | 1.23M | 4.06M | 429.00K |
| Receivables | 76.72M | 70.29M | 13.87M | 1.23M | 4.06M | 429.00K |
| Inventory | 39.38M | 39.01M | 2.38M | |||
| Prepaid Expenses | 14.09M | 3.88M | 3.29M | 2.00M | 1.22M | 872.00K |
| Restricted Cash | 115.00K | |||||
| Other Current Assets | 1.22M | 612.00K | 63.00K | 117.00K | 150.00K | |
| Total Current Assets | 567.44M | 528.08M | 603.06M | 580.88M | 489.79M | 448.40M |
| Property, Plant & Equipment | 1.16M | 1.52M | 2.02M | 1.50M | 1.06M | 1.26M |
| Long-Term Investments | 123.97M | 119.52M | 29.83M | 5.47M | ||
| Other Long-Term Assets | 102.00K | 102.00K | 217.00K | 680.00K | 922.00K | |
| Total Assets | 692.67M | 529.71M | 724.82M | 612.88M | 497.24M | 449.66M |
| Accounts Payable | 3.57M | 16.58M | 11.63M | 9.96M | 4.35M | 5.67M |
| Accrued Expenses | 116.86M | 102.34M | 59.67M | 38.97M | 23.67M | 12.76M |
| Current Portion of Long-Term Debt | 12.12M | |||||
| Current Portion of Leases | 526.00K | 472.00K | 480.00K | 1.05M | 439.00K | 362.00K |
| Other Current Liabilities | 721.00K | 19.65M | 8.12M | 604.00K | 1.89M | |
| Total Current Liabilities | 120.96M | 120.12M | 103.55M | 58.10M | 29.07M | 20.68M |
| Long-Term Debt | 588.28M | 343.91M | 331.56M | 19.89M | ||
| Long-Term Leases | 607.00K | 1.05M | 1.58M | 588.00K | 722.00K | 711.00K |
| Total Liabilities | 709.85M | 465.08M | 436.69M | 58.68M | 29.79M | 41.29M |
| Common Stock | 9.00K | 9.00K | 9.00K | 8.00K | 7.00K | 6.00K |
| Additional Paid-In Capital | 1.63B | 1.57B | 1.51B | 1.46B | 1.16B | 952.02M |
| Retained Earnings | -1.65B | -1.51B | -1.22B | -902.40M | -693.04M | -543.70M |
| Comprehensive Income & Other | -1.67M | 452.00K | 163.00K | 218.00K | -806.00K | 45.00K |
| Total Common Equity | -17.18M | 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
| Shareholders' Equity | -17.18M | 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
| Total Liabilities & Equity | 692.67M | 529.71M | 724.82M | 612.88M | 497.24M | 449.66M |
| Total Debt | 589.41M | 345.43M | 345.74M | 1.64M | 1.16M | 20.97M |
| Net Cash (Debt) | -152.16M | 68.25M | 237.17M | 575.95M | 483.24M | 425.86M |
| Net Cash Per Share | -1.72 | 0.79 | 2.77 | 8.18 | 7.95 | 7.94 |
| Filing Date Shares Outstanding | 90.03M | 88.20M | 86.02M | 84.97M | 68.44M | 55.01M |
| Total Common Shares Outstanding | 89.99M | 87.41M | 85.69M | 84.83M | 68.11M | 54.98M |
| Working Capital | 446.47M | 407.96M | 499.51M | 522.78M | 460.72M | 427.71M |
| Book Value Per Share | -0.19 | 0.74 | 3.36 | 6.53 | 6.86 | 7.43 |
| Tangible Book Value | -17.18M | 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
| Tangible Book Value Per Share | -0.19 | 0.74 | 3.36 | 6.53 | 6.86 | 7.43 |
| Machinery | 439.00K | 252.00K | 252.00K | 252.00K | 541.00K | |
| Leasehold Improvements | 167.00K | 167.00K | 167.00K | 167.00K | 167.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -209.48M | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| Depreciation & Amortization | 18.00K | 6.00K | 8.00K | 12.00K | 33.00K | 43.00K |
| Other Amortization | 537.00K | 228.00K | 30.00K | |||
| Loss (Gain) From Sale of Investments | -4.69M | -10.75M | -13.47M | -14.80M | -3.38M | 644.00K |
| Stock-Based Compensation | 52.61M | 47.50M | 43.03M | 30.95M | 16.02M | 13.32M |
| Provision & Write-off of Bad Debts | 3.67M | |||||
| Other Operating Activities | 2.67M | 1.11M | 989.00K | 739.00K | 1.34M | -202.00K |
| Change in Accounts Receivable | -21.46M | -30.39M | -7.60M | |||
| Change in Inventory | -14.04M | -32.09M | -366.00K | |||
| Change in Accounts Payable | -10.25M | 4.95M | 1.67M | 5.61M | -1.32M | 2.16M |
| Change in Unearned Revenue | -13.13M | |||||
| Change in Other Net Operating Assets | 26.74M | -21.79M | 19.57M | 26.25M | 2.98M | 1.38M |
| Operating Cash Flow | -177.36M | -322.98M | -274.90M | -160.60M | -133.68M | 29.13M |
| Capital Expenditures | -96.00K | -187.00K | -129.00K | |||
| Sale of Property, Plant & Equipment | 225.00K | |||||
| Investment in Securities | -73.32M | 290.22M | -219.78M | 117.61M | -186.41M | -40.74M |
| Investing Cash Flow | -73.42M | 290.04M | -219.78M | 117.61M | -186.19M | -40.87M |
| Long-Term Debt Repaid | -21.00M | |||||
| Net Debt Issued (Repaid) | 243.84M | -21.00M | ||||
| Issuance of Common Stock | 25.96M | 13.68M | 9.71M | 278.18M | 193.25M | 117.89M |
| Other Financing Activities | 343.65M | -14.04M | 576.00K | |||
| Financing Cash Flow | 269.79M | 13.68M | 353.37M | 264.13M | 172.25M | 118.46M |
| Net Cash Flow | 19.02M | -19.27M | -141.31M | 221.14M | -147.61M | 106.72M |
| Free Cash Flow | -177.46M | -323.17M | -274.90M | -160.60M | -133.68M | 29.00M |
| Free Cash Flow Margin | -61.26% | -187.50% | -1,160.91% | 20.76% | ||
| Free Cash Flow Per Share | -2.00 | -3.73 | -3.21 | -2.28 | -2.20 | 0.54 |
| Levered Free Cash Flow | -118.14M | -209.80M | -155.26M | -82.37M | -76.27M | 32.03M |
| Unlevered Free Cash Flow | -89.24M | -188.92M | -152.21M | -82.24M | -74.31M | 33.22M |
| Cash Interest Paid | 2.06M | 2.00M | ||||
| Change in Working Capital | -19.01M | -79.32M | 13.27M | 31.86M | 1.66M | -9.60M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.17B | 1.83B | 1.13B | 1.83B | 1.73B | 1.18B |
| Enterprise Value | 1.32B | 1.72B | 722.89M | 1.46B | 1.38B | 969.12M |
| Last Close Price | 13.10 | 21.01 | 13.22 | 21.61 | 25.45 | 21.89 |
| PE Ratio | 47.49 | |||||
| PS Ratio | 4.04 | 10.60 | 47.65 | 8.47 | ||
| PB Ratio | 28.25 | 3.92 | 3.31 | 3.71 | 2.90 | |
| P/TBV Ratio | 28.25 | 3.92 | 3.31 | 3.71 | 2.90 | |
| P/FCF Ratio | 40.81 | |||||
| P/OCF Ratio | 40.63 | |||||
| EV/Sales Ratio | 4.56 | 9.96 | 30.53 | 6.94 | ||
| EV/EBITDA Ratio | 36.90 | |||||
| EV/EBIT Ratio | 36.96 | |||||
| EV/FCF Ratio | 33.42 | |||||
| Debt / Equity Ratio | -34.31 | 5.34 | 1.20 | 0.00 | 0.00 | 0.05 |
| Debt / EBITDA Ratio | 0.79 | |||||
| Debt / FCF Ratio | 0.72 | |||||
| Net Debt / Equity Ratio | -8.86 | -1.06 | -0.82 | -1.04 | -1.03 | -1.04 |
| Net Debt / EBITDA Ratio | -0.85 | 0.25 | 0.70 | 2.50 | 3.19 | -16.21 |
| Net Debt / FCF Ratio | -0.86 | 0.21 | 0.86 | 3.59 | 3.62 | -14.68 |
| Asset Turnover | 0.47 | 0.28 | 0.04 | 0.37 | ||
| Inventory Turnover | 8.41 | 12.84 | ||||
| Quick Ratio | 4.25 | 4.03 | 5.76 | 9.96 | 16.81 | 21.62 |
| Current Ratio | 4.69 | 4.40 | 5.82 | 10.00 | 16.85 | 21.68 |
| Return on Equity (ROE) | -426.43% | -161.82% | -75.69% | -40.98% | -34.10% | 7.55% |
| Return on Assets (ROA) | -17.94% | -27.21% | -31.74% | -25.89% | -20.03% | 4.37% |
| Return on Capital Employed (ROCE) | -31.20% | -66.70% | -54.70% | -41.40% | -32.40% | 6.10% |
| Earnings Yield | -18.07% | -15.63% | -28.25% | -11.42% | -8.62% | 2.11% |
| FCF Yield | -15.17% | -17.70% | -24.36% | -8.76% | -7.71% | 2.45% |
| Buyback Yield / Dilution | -2.25% | -1.17% | -21.67% | -15.82% | -13.31% | -29.81% |